TXA Linked to Lower Reoperation Odds in Posttonsillectomy Hemorrhage

Tonsillectomy remains a cornerstone of pediatric surgical practice, with approximately 289,000 procedures performed annually in the United States for children under 15 years of age [1]. While the surgery is routine, secondary posttonsillectomy hemorrhage, defined as bleeding occurring more than 24 hours postoperatively, complicates up to 5% of cases and presents a risk for life-threatening airway compromise [1, 2]. Emergency management is frequently hindered by poor visualization and the anatomical difficulty of applying direct pressure to the oropharynx, where traditional hemostatic agents like silver nitrate often prove insufficient [1, 3]. Although prophylactic administration of tranexamic acid during the initial surgery has not demonstrated a clear reduction in bleeding rates, there is increasing clinical interest in its role as a rescue therapy [4, 5, 6]. Recent quality improvement data indicate that standardized protocols using this antifibrinolytic, a medication that prevents the enzymatic breakdown of fibrin clots, can significantly reduce the need for return to the operating room [7]. A new retrospective analysis of 19,572 emergency encounters found that tranexamic acid administration was associated with lower adjusted odds of reoperation (adjusted odds ratio 0.66; 95% confidence interval, 0.56 to 0.77), though it did not significantly impact hospital admission rates [8, 9].